Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature - PubMed (original) (raw)

Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission.

Stockbauer A, Beyer L, Huber M, Kreuzer A, Palleis C, Katzdobler S, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Garibotto V, Nicastro N, Lathuilière A, Lemstra AW, van Berckel BNM, Pilotto A, Padovani A, Ochoa-Figueroa MA, Davidsson A, Camacho V, Peira E, Bauckneht M, Pardini M, Sambuceti G, Aarsland D, Nobili F, Gross M, Vöglein J, Perneczky R, Pogarell O, Buerger K, Franzmeier N, Danek A, Levin J, Höglinger GU, Bartenstein P, Cumming P, Rominger A, Brendel M. Stockbauer A, et al. Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):1023-1034. doi: 10.1007/s00259-023-06493-w. Epub 2023 Nov 16. Eur J Nucl Med Mol Imaging. 2024. PMID: 37971501 Free PMC article.